Alzheimer's & dementia (New York, N. Y.)

Keyphrases

Publications

volume 9, number 2, 2023

Ivelina Gueorguieva, Brian A Willis, Laiyi Chua, Kay Chow, C Steven Ernest, Jian Wang, Sergey Shcherbinin, John R Sims, Emmanuel Chigutsa
Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Ivelina Gueorguieva, Brian A Willis, Laiyi Chua, Kay Chow, C Steven Ernest, Jian Wang, Sergey Shcherbinin, John R Sims, Emmanuel Chigutsa
Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Ivelina Gueorguieva, Brian A Willis, Laiyi Chua, Kay Chow, C Steven Ernest, Jian Wang, Sergey Shcherbinin, John R Sims, Emmanuel Chigutsa
Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Johanne Eliacin, Angelina J Polsinelli, Francine Epperson, Sujuan Gao, Sarah Van Heiden, Glenda Westmoreland, Ralph Richards, Mollie Richards, Christopher Campbell, Hugh Hendrie, Shannon L Risacher, Andrew J Saykin, Sophia Wang
Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Alex Pena-Garcia, Ralph Richards, Mollie Richards, Christopher Campbell, Hank Mosley, Joseph Asper, Johanne Eliacin, Angelina Polsinelli, Liana Apostolova, Hugh Hendrie, Andrew Tackett, Caprice Elliott, Sarah Van Heiden, Sujuan Gao, Andrew Saykin, Sophia Wang, null null
Accelerating diversity in Alzheimer's disease research by partnering with a community advisory board. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
María P Aranda, David X Marquez, Dolores Gallagher-Thompson, Adriana Pérez, Julio C Rojas, Carl V Hill, Yarissa Reyes, Peggye Dilworth-Anderson, Elena Portacolonem
A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Oanh L Meyer, Van Ta Park, Alka M Kanaya, Sarah Tomaszewski Farias, Ladson Hinton, Quyen Q Tiet, Quyen Vuong, Stephanie Nguyen, Danielle Harvey, Rachel A Whitmer
Inclusion of Vietnamese Americans: Opportunities to understand dementia disparities. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Luis D Medina, Steven Paul Woods, Rebecca Mullen, Samantha E John, Mark Kunik, Peter Pressman, Stacey Moeller, Michelle Martinez, Mirna Arroyo Miranda, Michelle Stocker, Natalie Lopez-Esquibel, Jennifer Vardeman
A boot camp translation of Alzheimer's disease in Hispanic/Latino communities. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Maria A E Dreves, Argonde C van Harten, Leonie N C Visser, Hanneke Rhodius-Meester, Sebastian Köhler, Minke Kooistra, Janne M Papma, Madison I J Honey, Marco M Blom, Ellen M A Smets, Marjolein E de Vugt, Charlotte E Teunissen, Wiesje M van der Flier, null null
Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease). Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Jeffrey Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca, Feixiong Cheng
Alzheimer's disease drug development pipeline: 2023. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Selena E Washington, Emily Cler, Cameron Lowery, Susan L Stark
Down syndrome and Alzheimer's disease: A scoping review of functional performance and fall risk. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
J Scott Andrews, Urvi Desai, Noam Y Kirson, Brandy R Matthews
Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019). Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
J Scott Andrews, Urvi Desai, Noam Y Kirson, Brandy R Matthews
Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019). Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
J Scott Andrews, Urvi Desai, Noam Y Kirson, Brandy R Matthews
Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019). Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Christopher H Van Dyck, Ryan S O'Dell, Adam P Mecca
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Yaning Wang
An insider's perspective on FDA approval of aducanumab. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Christopher H Van Dyck, Ryan S O'Dell, Adam P Mecca
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)
Byron Creese, Ryan Arathimos, Dag Aarsland, Clive Ballard, Helen Brooker, Adam Hampshire, Anne Corbett, Zahinoor Ismail
Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (2) (2023)

volume 9, number 3, 2023

Stephanie J Monroe
Discussing inconvenient truths about the lack of generalizability of Alzheimer's research to minoritized populations. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Claire M Erickson, Nathaniel A Chin, Hannah L Rosario, Amanda Peterson, Sterling C Johnson, Lindsay R Clark
Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Jeffrey Cummings
Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Beth A Kallmyer, David Bass, Matthew Baumgart, Christopher M Callahan, Sarah Dulaney, Leslie C Evertson, Sam Fazio, Katherine S Judge, Quincy Samus
Dementia care navigation: Building toward a common definition, key principles, and outcomes. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Atticus H Hainsworth, Ottavio Arancio, Fanny M Elahi, Jeremy D Isaacs, Feixiong Cheng
PDE5 inhibitor drugs for use in dementia. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Barbara Fischer, Carol Ann Van Hulle, Rebecca Langhough, Derek Norton, Megan Zuelsdorff, Diane Carol Gooding, Mary F Wyman, Adrienne Johnson, Nickolas Lambrou, Taryn James, Shenikqua Bouges, Fabu Phillis Carter, Hector Salazar, Kristopher Kirmess, Mary Holubasch, Matthew Meyer, Venky Venkatesh, Tim West, Philip Verghese, Kevin Yarasheski, Cynthia M Carlsson, Sterling C Johnson, Sanjay Asthana, Carey E Gleason
Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohort. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
ZhiDi Deng, Esme Fuller-Thomson
Could cerebrospinal fluid leak contribute to the link between traumatic brain injury and dementia? Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Sharon Sanz Simon, Sonia Maria Dozzi Brucki, Luciana Mascarenhas Fonseca, Jacqueline Becker, Carolina Cappi, Andrea Horvath Marques, Patricia C Heyn, Priscila Dib Gonçalves, Silvia S Martins, Geraldo Busatto, Claudia Kimie Suemoto, Ricardo Nitrini, Paulo Caramelli, Monica Sanches Yassuda, Eliane Correa Miotto, Lea Tenenholz Grinberg, Miguel Arce Renteria, Margarita Alegria, Yaakov Stern, Monica Rivera-Mindt, Laiss Bertola
The (in)visible Brazilians: A perspective review on the need for brain health and dementia research with Brazilian immigrants in the United States. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Jessica de Leon, Ivan Bondoc, Eugenie Mamuyac, Lainie Posecion, Eduardo Europa, Lolita C Kintanar, Niecholle Roco, Mikkael Lamoca, Danielle P Escueta, Van M Ta Park
The development of the Cognitive Assessment for Tagalog Speakers (CATS): A culturally and linguistically tailored test battery for Filipino Americans. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Sergey Shcherbinin, Amanda Morris, Ixavier A Higgins, Ilke Tunali, Ming Lu, Carmen Deveau, Sudeepti Southekal, Vikas Kotari, Cynthia D Evans, Anupa K Arora, Emily C Collins, Michael Pontecorvo, Mark A Mintun, John R Sims
Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Adam Turnbull, Aaron Seitz, Feng V Lin
Improving comparability across cognitive training trials for brain aging: A focus on interoperability. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Fred B Ketchum, Nathaniel A Chin, Claire Erickson, Nickolas H Lambrou, Kristin Basche, Carey E Gleason, Lindsay Clark
The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Jordan Savold, Michele Cole, Roland J Thorpe
Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Karen B Hirschman, Molly McHugh, Brianna Morgan
An integrative review of measures of transitions and care coordination for persons living with dementia and their caregivers. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Stacey J Sukoff Rizzo, Gregg Homanics, David J Schaeffer, Lauren Schaeffer, Jung Eun Park, Julia Oluoch, Tingting Zhang, Annat Haber, Nicholas T Seyfried, Benedict Paten, Anna Greenwood, Takeshi Murai, Sang Ho Choi, Hasi Huhe, Julia Kofler, Peter L Strick, Gregory W Carter, Afonso C Silva
Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Stefan J Teipel, Annika Spottke, Henning Boecker, Marcel Daamen, Erika Graf, Jörg Sahlmann, Ralph Buchert, Wolfgang Mohnike, Konrad Mohnike, Jens Kurth, Frank Jessen, Bernd J Krause
Patient-related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)
Emily D Clark, Jamie Perin, Nathan Herrmann, Olga Brawman-Mintzer, Krista L Lanctôt, Alan J Lerner, Jacobo Mintzer, Prasad R Padala, Paul B Rosenberg, Susie Sami, David M Shade, Christopher H van Dyck, Anton P Porsteinsson, null null
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study. Alzheimer's & dementia (New York, N. Y.) 9 (3) (2023)

volume 9, number 4, 2023

Oula Hatahet, Florian Roser, Mohamed L Seghier
Cognitive decline assessment in speakers of understudied languages. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Mark A Espeland, Denise K Houston, Kathleen M Hayden, Judy L Bahnson, Peter J Huckfeldt, Haiying Chen, Michael P Walkup, Rebecca H Neiberg, Mia Yang, Tara Beckner, Lynne E Wagenknecht, null null
Rationale, design, and cohort characteristics of the Action for Health in Diabetes Aging study. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Kathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, Miguel Garcia, David S Miller, Fanni Natanegara, Lars Lau Raket, Weining Robieson, Eric R Siemers, Maria C Carrillo, Christopher J Weber
Decision making in clinical trials: Interim analyses, innovative design, and biomarkers. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Ayesha Khan, Richard Killick, Daniel Wirth, Dominique Hoogland, Kalina Hristova, Jakob P Ulmschneider, Christopher R King, Martin B Ulmschneider
Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Penny Gosselin, Dylan X Guan, Eric E Smith, Zahinoor Ismail
Temporal associations between treated and untreated hearing loss and mild behavioral impairment in older adults without dementia. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Cynthia D Jesudason, Emily R Mason, Shaoyou Chu, Adrian L Oblak, June Javens-Wolfe, Mustapha Moussaif, Greg Durst, Philip Hipskind, Daniel E Beck, Jiajun Dong, Ovini Amarasinghe, Zhong-Yin Zhang, Adam K Hamdani, Kratika Singhal, Andrew D Mesecar, Sarah Souza, Marlene Jacobson, Jerry Di Salvo, Disha M Soni, Murugesh Kandasamy, Andrea R Masters, Sara K Quinney, Suzanne Doolen, Hasi Huhe, Stacey J Sukoff Rizzo, Bruce T Lamb, Alan D Palkowitz, Timothy I Richardson
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Ronald C Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee M Sink, Maria C Carrillo, Christopher J Weber
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Hiroko H Dodge, Steven E Arnold
One step forward to personalized medicine? Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Barry D Greenberg, Cynthia A Lemere, Lisa L Barnes, Kathleen M Hayden, Walter A Kukull, Esther S Oh, Peter J Snyder, Mark Supiano, Peggye Dilworth-Anderson
Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Shveta Bathla, Dibyadeep Datta, Feng Liang, Nicolas Barthelemy, Robyn Wiseman, Barbara S Slusher, Jennifer Asher, Caroline Zeiss, Dil Ekanayake-Alper, Daniel Holden, Gordon Terwilliger, Alvaro Duque, Jon Arellano, Christopher van Dyck, Randall J Bateman, Zhongcong Xie, Angus C Nairn, Amy F T Arnsten
Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Caterina Padulo, Carlo Sestieri, Miriam Punzi, Eleonora Picerni, Piero Chiacchiaretta, Maria Giulia Tullo, Alberto Granzotto, Antonello Baldassarre, Marco Onofrj, Antonio Ferretti, Stefano Delli Pizzi, Stefano L Sensi, null null
Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Amanda N Szabo-Reed, Tristyn Hall, Eric D Vidoni, Angela Van Sciver, Monica Sewell, Jeffrey M Burns, C Munro Cullum, William P Gahan, Linda S Hynan, Diana R Kerwin, Heidi Rossetti, Ann M Stowe, Wanpen Vongpatanasin, David C Zhu, Rong Zhang, Jeffrey N Keller, Ellen F Binder
Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD). Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Samuel E Gandy
Open peer commentary on "Prescribing anti-amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions". Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Genevieve Zara Steiner, Alan Bensoussan, Elana R Andrews-Marney, Mahmoud A Al-Dabbas, Adele E Cave, Christine L Chiu, Katerina Christofides, Frances M De Blasio, Lauren S Dewsbury, Naomi L Fagan, Jack S Fogarty, Lena C Hattom, Mark I Hohenberg, Deyyan Jafar, Diana Karamacoska, Chai K Lim, Jianxun Liu, Najwa-Joelle Metri, D Vincent Oxenham, Holly Ratajec, Nikita Roy, Danielle G Shipton, David Varjabedian, Dennis H Chang
A randomized, double-blind, placebo-controlled, parallel-group 12-week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)
Jennifer Erichsen, Suzanne Craft
Targeting immunometabolic pathways for combination therapy in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 9 (4) (2023)